PENTAMBODY
Live / Registered — Registered (as of 05 Nov 2019)
What this means for you
Registered since 05 Nov 2019. The owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 79225073
- Registration number
- 5899437
- Mark type
- Stylized text
- Filed
- 29 Jun 2017
- Published for opposition
- 20 Aug 2019
- Registered
- 05 Nov 2019
Goods and services
- Class 005 — Pharmaceuticals: Medicines for human purposes, pharmaceutical preparations, drugs for medical purposes, biological preparations for medical purposes, biochemical drugs, and pharmaceutical preparations in the form of injection, each of which being, namely, for treating one or more of autoimmune diseases, immune response against grafts, allergic reactions, neurodegenerative diseases, neoplastic diseases and cellular proliferative disorders, arthritis, rheumatoid arthritis, psoriasis, multiple sclerosis (MS), ulcerative colitis, Crohn's disease, systemic lupus erythematosus (SLE), glomerulonephritis, dilated cardiomyopathy-like diseases, Sjogren's syndrome, allergic contact dermatitis, polymyositis, scleroderma, periarteritis nodosa, rheumatic fever, vitiligo, insulin-dependent diabetes mellitus, Behcet's syndrome, chronic thyroiditis, Parkinson's disease, Huntington's disease, Machado-Joseph disease, amyotrophic lateral sclerosis (ALS), Creutzfeldt - Jakob disease, leukemia, lymphoma, myeloma, brain tumors, head and neck squamous cell carcinoma, non-small cell lung cancer (NSCLC), nasopharyngeal cancer, esophageal cancer, stomach cancer, pancreatic cancer, gallbladder cancer, liver cancer, colorectal cancer, breast cancer, ovarian cancer, cervical cancer, endometrial cancer, uterine sarcoma, prostate cancer, bladder cancer, renal cell carcinoma, melanoma, and combinations thereof; nutritional supplements and dietetic substances adapted for medical use, namely, dietetic foods adapted for medical use and dietetic beverages adapted for medical use
Owner
- BEIJING HANMI PHARMACEUTICAL CO., LTD., Beijing, CN
- BEIJING HANMI PHARMACEUTICAL CO., LTD., Beijing, CN
- BEIJING HANMI PHARMACEUTICAL CO., LTD., Beijing, CN
Prosecution history
- 05 Nov 2024 — COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED
- 24 Apr 2020 — FINAL DECISION TRANSACTION PROCESSED BY IB
- 02 Mar 2020 — GENERIC MADRID TRANSACTION SENT TO IB
- 02 Mar 2020 — GENERIC MADRID TRANSACTION CREATED
- 05 Feb 2020 — FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
- 05 Nov 2019 — REGISTERED-PRINCIPAL REGISTER
- 20 Aug 2019 — OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
- 20 Aug 2019 — PUBLISHED FOR OPPOSITION
- 31 Jul 2019 — NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
- 31 Jul 2019 — NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
- 31 Jul 2019 — NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
- 18 Jul 2019 — APPROVED FOR PUB - PRINCIPAL REGISTER
- 05 Jul 2019 — NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB
- 20 Jun 2019 — TEAS/EMAIL CORRESPONDENCE ENTERED
- 20 Jun 2019 — CORRESPONDENCE RECEIVED IN LAW OFFICE